Ausencia de beneficio, en el screening de cáncer de prostata con PSA.
Al parecer el uso de éste antígeno para detectar pacientes en riesgo de padecer cáncer de próstata no disminuye la mortalidad por éste cáncer y sí aumenta el número de intervenciones innecesarias.
Medical News: No Mortality Benefit Seen from PSA Screening – in Oncology/Hematology, Prostate Cancer from MedPage Today http://ht.ly/8ltcK
Related articles
- Prostate cancer screening does not reduce death rates, research shows (guardian.co.uk)
- Study shows routine prostate cancer testing does not save lives (mysanantonio.com)
- Routine Prostate Cancer Screening Doesn’t Reduce Risk of Death – ABC News (abcnews.go.com)
- Extra prostate tests didn’t cut death rates in study (cbc.ca)
- Study shows no evidence of a mortality benefit to PSA screening (eurekalert.org)
Dr. Julián López Pérez 
Deja un comentario